Arcutis Biotherapeutics Inc (NAS:ARQT)
$ 25.14 -0.22 (-0.87%) Market Cap: 3.16 Bil Enterprise Value: 3.04 Bil PE Ratio: 122.04 PB Ratio: 14.28 GF Score: 56/100

Q1 2026 Arcutis Biotherapeutics Inc Earnings Call Transcript

May 6, 2026 / 08:30 PM GMT
Release Date Price: $24.17 (+3.20%)


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

ARQT.OQ - Arcutis Biotherapeutics Inc
Q1 2026 Arcutis Biotherapeutics Inc Earnings Call
May 06, 2026 / 08:30PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Good day, and thank you for standing by. Welcome to the Acutis Biotherapeutics, Inc. First Quarter 2026 Earnings Conference Call. At this time, all participants are on listen-only mode.

After this previous presentation, there'll be a question-and-answer session.

To ask a question during this session, you'll need to press *11 on your telephone. You will then hear an automated message inviting your hand is raised.

To withdraw your question, please press *11 again.

Please be advised that today's conference is being recorded. I would like to end conference with your first speaker today, Brian Schoelkoff, Head of Investor Relations. Please go ahead.

-----------------------------
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot